As recently updated by PTCB.org, there are six core sections of the Federal Requirements knowledge domain. Below, we have put together the key sections as well as examples of the kind of detail that gets tested:
| Section | Topic | Examples / Description |
| 2.1 | Federal requirements for storage, handling, and disposal of non-hazardous, hazardous (e.g. P-list), and pharmacological substances and wastes | Covers proper procedures under EPA and OSHA regulations for storing, labeling, and disposing of medications. Includes handling of P-listed hazardous waste (e.g. warfarin, nicotine) and ensuring segregation of pharmaceutical waste to prevent contamination. |
| 2.2 | Federal requirements for controlled substance prescriptions (new, refill, transfer) and DEA controlled substance schedules | Focuses on the DEA Controlled Substances Act (CSA); defines Schedules I–V, prescription validity, refill limits (e.g. Schedule II: no refills), and transfer policies (Schedule III–V: one transfer only). Includes correct use of DEA numbers. |
| 2.3 | Federal requirements for receiving, storing, ordering, labeling, dispensing, returning, take-back programs for, loss or theft of, and destroying controlled substances |
Involves DEA Form 222 for ordering Schedule II drugs, DEA Form 106 for theft or loss, and DEA Form 41 for destruction. Includes secure storage (locked cabinets or dispersed inventory), proper recordkeeping, and participation in take-back programs. |
| 2.4 | Federal restricted drug programs and related medication-processing requirements (e.g. pseudoephedrine, REMS) | Encompasses Combat Methamphetamine Epidemic Act (CMEA) rules for pseudoephedrine sales (daily and monthly limits, ID verification, logbook) and FDA REMS programs such as iPLEDGE (isotretinoin), Clozapine REMS, and Thalomid REMS to ensure safe use. |
| 2.5 | FDA requirements for medication recalls | Details FDA recall classifications (Class I–III), procedures for identifying affected lots, notifying patients or providers, and returning or quarantining recalled products. May involve both manufacturer-initiated and FDA-mandated recalls. |
| 2.6 | FDA product serialization, tracking, tracing, handling, and quarantining requirements (Drug Supply Chain Security Act – DSCSA) | Focuses on tracking and tracing prescription drugs through the supply chain to prevent counterfeit or diverted products. Includes requirements for product identifiers (2D barcodes), transaction history, and quarantine procedures for suspect medications. |
Below you can find sample federal requirements questions that reflect the style and standard of questions tested on the PTCB exam.
Warfarin (at certain concentrations, especially unused commercial chemical products) is a P-listed hazardous waste (P001) under the Environmental Protection Agency Resource Conservation and Recovery Act (RCRA) regulations.
Because it is the sole active ingredient, an unused commercial product must be managed as hazardous waste.
P-listed wastes are considered acutely hazardous and are subject to strict storage, labeling, and disposal requirements.
Schedule II medications have no refills permitted under federal law.
Schedule III and IV medications may be refilled up to 5 times within 6 months from the date written. Therefore, diazepam with 5 refills within 6 months is compliant.
Alprazolam is incorrect because it states, “6 refills in 5 months”. Even though “6 refills in 5 months” is within the 6-month time limit, it exceeds the maximum number of refills (5) allowed by federal law.
Adderall is a Schedule II controlled substance.
Under federal law, Schedule II prescriptions cannot be refilled or transferred between pharmacies.
A new prescription must be issued by the prescriber.
Under federal law enforced by the DEA, pharmacies must notify the DEA immediately upon discovery of a significant loss or theft and submit DEA Form 106.
The report may be filed electronically.
Under the Combat Methamphetamine Epidemic Act (CMEA), products containing pseudoephedrine must:
A prescription is not required federally (though some states may require one).
For manufacturer-initiated or FDA-monitored recalls:
Recall Classifications Overview:
The DSCSA, enforced by the US Food and Drug Administration, requires manufacturers to place a product identifier on most prescription drug packages and homogeneous cases.
The identifier includes:
This supports electronic, interoperable tracking of prescription drugs through the supply chain.







Work your way through study notes, cheat sheets, and exam-like practice questions that detail all the essential facts technicians need to know to succeed at the federal requirements knowledge domain.